Medical Indications definition

Medical Indications means all medical indications applicable to the Product. "NDA" means New Drug Application as noted on Appendix C.

Examples of Medical Indications in a sentence

  • The rates of royalty specified above shall be determined separately for any CC or Backup-Compound taking into account the accumulated Net Sales over all Product(s) and all Medical Indications with regard to such CC or Backup-Compound.

  • Aspire shall be responsible for filing all reports required to be filed in order to maintain any Regulatory Approvals granted for the Product and Medical Indications in the Territory, including, without limitation, Adverse Drug Experience reports.

Related to Medical Indications

  • geographical indication , in relation to goods, means an indication which identifies such goods as agricultural goods, natural goods or manufactured goods as originating, or manufactured in the territory of a country, or a region or locality in that territory, where a given quality, reputation or other characteristic of such goods is essentially attributable to its geographical origin and in case where such goods are manufactured goods one of the activities of either the production or of processing or preparation of the goods concerned takes place in such territory, region or locality, as the case may be.

  • Initial Indication means the use of a Product for the treatment of opioid addiction.

  • Diagnostic Product means an assemblage of reagents, including but not limited to reagents packaged in the form of a kit, useful in performing a Licensed Service.

  • Collaboration Product means a pharmaceutical product containing or comprising Compound in any dosage form alone, or in combination with, one or more other pharmaceutically active ingredients, and any and all Improvements thereto.

  • Licensed Compounds means: (a) Research Program Active Compounds; (b) Novartis Active Compounds; (c) salts, hydrates, solvates, esters, metabolites, intermediates, stereoisomers and polymorphs of Research Program Active Compounds or Novartis Active Compounds; and (d) prodrugs of Research Program Active Compounds or Novartis Active Compounds (any of the foregoing, a “Licensed Compound”).